- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/12 - Aerosols; Foams
Patent holdings for IPC class A61K 9/12
Total number of patents in this class: 2058
10-year publication summary
137
|
130
|
228
|
152
|
178
|
170
|
147
|
131
|
123
|
29
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Journey Medical Corporation | 93 |
34 |
VYNE Therapeutics Inc. | 64 |
29 |
Galderma Research & Development | 440 |
24 |
Foamix Ltd. | 25 |
19 |
LEO Pharma A/S | 455 |
17 |
Camurus AB | 153 |
16 |
Pearl Therapeutics, Inc. | 34 |
14 |
Theravance Biopharma R&D IP, LLC | 550 |
14 |
Boehringer Ingelheim International GmbH | 4629 |
12 |
Board of Regents, The University of Texas System | 5370 |
12 |
Alexza Pharmaceuticals, Inc. | 75 |
12 |
Chiesi Farmaceutici S.p.A. | 940 |
12 |
Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 220 |
11 |
Boehringer Ingelheim Pharma GmbH & Co. Kg | 790 |
10 |
S. C. Johnson & Son, Inc. | 2869 |
10 |
Mexichem Amanco Holding S.A. de C.V. | 126 |
10 |
Mexichem Fluor, Sociedad Anonima de Capital Variable | 200 |
10 |
Precision Dermatology, Inc. | 28 |
10 |
Toko Yakuhin Kogyo Kabushiki Kaisha | 17 |
10 |
Toko Yakuhin Kogyo Co., Ltd. | 26 |
10 |
Other owners | 1762 |